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Material and Methods 
Yeast surface display of domain 11 and IGF2 binding screens.   
  The yeast surface display vector, pPICFlagDomain 11-Agα1, was generated by 
ligating IGF2R domain 11 (residues 1508-1654) into the EcoRI and AvrII restriction sites of 
pPIC9K preceded by the Flag peptide and followed by the C-terminal region of the 
Saccharomyces cerevisiae AGα1 gene. The resulting protein is a N-terminal Flag tagged 
fusion of domain 11 and the C-terminal domain (residues 311-650) of α-agglutinin, which 
targets the fusion protein to the cell surface through the secretory pathway, where it is 
attached by a GPI anchor (1). The pLITMUS-Domain 11 vector was also generated by 
ligation of the Domain 11 insert into the EcoRI and AvrII restriction sites in the multipurpose 
cloning pLITMUS28i vector.  Loop-specific mutant libraries were generated by either whole 
plasmid PCR (using Kappa HiFi HotStart DNA polymerase, Kappa Biosystems, or Phusion 
Polymerase, Finnzymes), using tail-to-tail mutagenic primers pairs (Supplementary Table 1) 
and the pPICFlagDomain11-Agα1 vector or the pLITMUS-Domain 11 vector as template for 
the AB loop and the HI loop libraries, respectively. The PCR product was treated with DpnI, 
self-ligated and transformed into XL10-Gold® ultra-competent E. coli cells (Stratagene) to 
generate the E. coli libraries. The presence of random amino acid mutations in the desired 
positions was confirmed by sequencing. In the case of the HI loop library, a midiprep of the 
E. coli pLITMUS-Domain 11HI library (containing 8.3 × 106 clones) was digested with EcoRI 
and AvrII and the excised HI loop-mutated domain 11 was then ligated into the pPICFlag-
Agα1 and transformed into the ultra-competent E. coli cells to generate the E. coli 
pPICFlagDomain 11HI-Agα library (containing 1.32 x 106 mutants). pPICFlagDomain 11AB-
Agα1 and pPICFlagDomain 11HI-Agα1 were linearised within the HIS4 gene by SalI 
digestion and electroporated into the histidine auxothrophic P. pastoris strain GS115 as 
described by (2). For selection, P. pastoris libraries were grown in histidine deficient minimal 
medium (MD=1.34% yeast nitrogen base (YNB), 4 × 10-5 % biotin, 2% dextrose).  
For surface display expression, P. pastoris yeast libraries selected on MD for 72 hr, were kept 
at 4 ºC for a further 24 hr and passaged on MD.  An excess of at least 10-fold of the library 
size of freshly grown cells was grown at 30ºC in BMGY  (1% yeast extract, 2% peptone, 
1.34% YNB, 4 x 10-5% biotin, 1% (v/v) glycerol, 100 mM potassium phosphate, pH 6.0) for 
24-48 hr.  Surface display of the mutated domain 11 was induced by transfer to BMMY (1% 
yeast extract, 2% peptone, 1.34% YNB, 4 × 10-5% biotin, 0.5% (v/v) methanol, 100 mM 
potassium phosphate, pH 6.0). For maintained induction, cultures were supplemented with 
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methanol to a concentration of 1% (v/v) every 24 hr for three days. Yeast cultures of control 
proteins (domain 11WT, domain 11AB3 and domain 11I1572A) were induced in the same manner. 
Freshly induced yeast cells displaying domain 11WT, domain 11AB3 and domain 
11I1572A were pelleted and washed with PBSA (PBS+0.5% (v/v) BSA). Aliquots of 5 × 105 
cells were incubated in PBSA for 1 hr at room temperature with anti-Flag M2 antibody 
(Sigma) and increasing concentrations of biotinylated IGF2 ranging from 15 pM to 1.5 µM in 
a total volume such that a 10-fold molar excess of IGF2 over the domain 11 displayed on the 
surface was maintained (assuming a maximum of 5x104 molecules per cell) (3). The cells 
were then pelleted, washed 3 times with cold PBSA and labeled with Alexa Fluor 488 goat 
anti-mouse IgG1 (Invitrogen) and Alexa Fluor® 647 streptavidin (Invitrogen) in a volume of 
50 µL for 30 min at 4 ºC. Negative controls with secondary only and a positive control with 
anti-Flag+Alexa Fluor 488 only were also included. The cells were pelleted, washed 3 times 
with cold PBSA and re-suspended in 1 mL of PBSA and run in CyAn ADP Cytometer 
(Dako). The yeast population was gated on forward- and side-scatter channels to remove 
debris and the percentage of double positive cells was measured for each IGF2 concentration. 
For the yeast loop libraries sorting, a 10-fold excess of the library population diversity 
was labeled in a similar manner, alongside the yeast cells displaying domain 11AB3. The cells 
were pelleted, washed with PBSA and incubated first with the Anti-Flag M2 antibody 
(Sigma) for 1 hr at room temperature followed by 3x PBSA washes. The subsequent 
incubation with 5 nM IGF2, maintaining a 10-fold molar excess of IGF2 over domain 11, 
was also carried out for 1hr at room temperature. After 3x PBSA washes, the yeast cells were 
incubated with Alexa Fluor 488 goat anti-mouse IgG1 (Invitrogen) and Alexa Fluor® 647 
streptavidin, Invitrogen) for 30 min-1 hr at 4 ºC. Negative and positive controls were 
similarly labeled and used, together with the yeast cells displaying domain 11AB3 (also labeled 
with 5 nM IGF2), to gate the library yeast cells that should display higher affinity binders on 
the surface (3). 
FACS gated cells were grown for 48 hr in YPD (1% yeast extract, 2% peptone, 2% 
dextrose) containing 100U mL-1 penicillin, 100 µg mL-1 streptomycin, 100 µg mL-1 
kanamycin and 0.5 mg mL-1 Geneticin. Genomic DNA was extracted using the YeaStar 
Genomic DNA kit (Zymoresearch). Mutated domain 11 was amplified by PCR from the 
genomic DNA using primers that incorporated EcoRI and AvrII restriction sites into the 
pPIC-HIS vector in frame with the α-factor secretion signal to generate pPIC-Domain 11 
construct of the mutants (4). The vector was then linearised with SalI and integrated into the 
HIS4 locus of the P. pastoris genome by electroporation (2). Yeast cells incorporating domain 
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11 into their genome were selected at 30 ºC on MD plates. Single yeast colonies were 
inoculated into 96 well plates containing 500 µl of BMGY and grown at 30 ºC for 24 hr 
(covered with a sterile breathable seal). Each plate contained a set of controls, including non 
transformed cells and cells secreting domain11WT, domain 11AB3 and domain 11I1572A mutants. 
The medium was replaced with BMMY and induction was sustained by supplementing with 
methanol to a final concentration of 1% (v/v) every 24 hr for two days.  
Supernatants (100 µl) containing the secreted domain 11 mutants, were transferred to 
a 96 well plate, diluted with 100 µL of HBS-EP (10 mM HEPES pH 7.4, 150 mM NaCl, 3 
mM EDTA, and 0.005% (v/v) surfactant P20) and screened for IGF2 binding ability by SPR 
on a Biacore 3000. Biotinylated IGF2 (GroPep, Aus) was immobilized on the flow cells of 
the sensor chip SA by affinity capture to streptavidin. Kinetic experiments were performed at 
25 ºC in HBS-EP at a flow-rate of 40 µL min-1 and consisted of a 2 min injection of diluted 
supernatant followed by a 2 min dissociation phase in HBS-EP running buffer, after which 
the binding surface was regenerated with a 2 min injection of 2M MgCl2. The resulting 
sensorgrams were visually analysed using the standard BiaEvaluation software version 4.0.1 
for Biacore 3000. Additionally, the dissociation phase was fitted to a first order exponential 
decay curve (Y=Y0·e-k off. x) from which the koff could be calculated. 
Protein expression and purification of M6P/ IGF2R domain 11 mutants for SPR studies.  
   For expression, yeast colonies selected on MD plates were grown at 30 ºC in 10 mL 
of BMGY for 24 hr and induced by being transferred to 50 mL BMMY. For maintained 
induction, cultures were supplemented with methanol to a final concentration of 1% (v/v) 
every 24 hr for two days. Supernatants were then subjected to SDS-PAGE and western blot 
using anti-His6 mouse monoclonal antibody conjugated to peroxidase (Roche Diagnostics, 
USA). Domain 11 secreting cultures were scaled up to 500 mL BMMY and grown for further 
72 hr and supplemented with 1% methanol every 24 hr. Supernatants were cleared by 
centrifugation (6000rpm for 20 min at 4 ºC in a Beckman-Coulter Avanti-J2 refrigerated 
centrifuge), diluted 5-fold in 20 mM sodium phosphate pH 8.0 buffer and His-purified using 
a Ni-NTA superflow column (Qiagen) on an Äkta FPLC system (GE Life Sciences, UK) 
washed with 50 mM imidazole and eluted with 250 mM imidazole. The fractions containing 
the protein were pooled and, when required, diluted in 20 mM MES pH 6.0 and purified 
using a Resource S column on an Äkta FPLC system (GE Life Sciences, UK). Purified 
proteins were dialyzed and concentrated using centrifugal filter units of 5 kDa cut-off 
(Millipore).  Protein concentration was determined spectrophotometrically (Nanodrop) using 
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the theoretical extinction coefficient calculated by ProtParam and protein size and 
homogeneity was verified using 12% SDS-PAGE.  
Structure-informed loop-specific site directed mutagenesis.   
  The domain 11AB3:IGF2 structure (PDB: 2L29) was used to identify residues in the 
binding loops that could interact with IGF2. These were manually mutated in Pymol v1.5 to 
determine whether or not they might stabilise the complex (http://www.pymol.org/). In 
addition the Robetta server (http://robetta.bakerlab.org/alascansubmit.jsp) was used to 
perform interface alanine scanning mutagenesis on the Domain11AB3 complex to identify 
residues important for complex formation. A number of possible amino acids were introduced 
at each site to assess the residue’s role in binding. M6P/IGF2R domain 11 sub-cloned from 
the pPICHis vector into pET26a (Novagen, Merck Chemicals Ltd, Nottingham, UK) was 
used as a template for site directed mutagenesis. The template was amplified in a 
thermocycler (PeqStar) using mutagenic primers and KOD DNA polymerase (Novagen) to 
introduce the mutations. Following amplification the parental DNA was digested with DpnI 
and transformed into E. coli 5α cells (NEB) for sequencing. The mutant proteins were 
expressed and refolded using existing protocols in E. coli BL21 (DE3) before the binding 
kinetics were analysed by SPR (5). 
Expression and purification of domain 11WT, domain 11AB5 and IGF2-domain 11AB5 
complexes for NMR.  
His6-tagged domain 11WT and domain 11AB5 (residues 1508-1654) cloned into pET26 
(Novagen, Merck Chemicals Ltd, Nottingham, UK) were transformed into E. coli BL21(DE3) 
CodonPlus™ competent cells, purified as inclusion bodies and refolded according to well-
established protocols (5).  Proteins were isotopically labelled using 1 g L-1 15N-ammonium 
chloride and/or 2 g L-1 13C6-glucose (99%, Cambridge Isotope Laboratories) in M9 minimal 
media.  Lyophilised IGF2 (Novozymes Biopharma, AU) was added to NMR samples of 15N-
single (dynamics studies) and 15N, 13C-double labeled domain 11AB5 mutant (structural studies) 
in a 1:1 ratio at pH 4, which provided optimum stability for the complex.  Structural 
calculations of the domain 11AB5 both free and complexed with IGF2 were as described for 
the domain 11AB3:IGF2 complex (5).  Validation was performed using the iCing online server 
(version r76; (https://nmr.cmbi.ru.nl/icing/iCing.html). The ensembles of NMR structures and 
associated NMR chemical shifts have been deposited with the protein database and 
BioMagResBank with the following accession codes: Free domain 11AB5 2M6T and IGF2 
bound domain 11AB5 2M68. 
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15N relaxation studies of domain11WT and domain 11AB5.  
NOE, 15N-T1 and 15N-T2 NMR relaxation data were acquired at two fields (600 and 
900 MHz) at 25 ºC on a Varian VNMRS or INOVA spectrometer respectively, both fitted 
with cryogenically cooled probe heads for domain 11WT and domain 11AB5.  T1 delays of 0.01, 
0.02*, 0.03, 0.05, 0.07, 0.10, 0.15, 0.30, 0.40, 0.6, 0.8, 1.0, 1.5, 2.0** and 2.5** s (*600 MHz 
only, **900 MHz only) and T2 delays of 0.1-2.1 s with intervals of 0.2 s were gathered using 
BioPack pulse sequences provided by VnmrJ 2.2.  T1 and T2 experiments were run in 
duplicate.  Automatic spectral compression (ASCOM) (6) was applied to increase 
signal:noise without increasing the length of the experiments.  NOE ratios were calculated 
between peak heights in HSQC spectra recorded both with and without NOE proton 
saturation.  At the beginning of each transient a 5 s ultra low power pulse was employed for 
those spectra without NOE and a 3 s proton saturation pulse with a 2 s delay (total 5 s) for 
those experiments with NOE. Data collected was processed (NMRPipe, (7)) and assigned 
(Analysis 2.1.5 (8)) before being exported for curve fitting and model free analysis (relax 
1.3.9 (9, 10).  Relaxation rates were calculated by an eleven parameter grid search, followed 
by simplex minimisation curve fitting to a two-parameter (I0, Rx) exponential decay. Monte 
Carlo error analysis used the standard deviation of simulated curves back calculated from 
fitted parameters across replicated spectra, or from the Sparky 3.113 (Goddard T. D.), with 
RMSD calculation of noise in a peak-free region of non-replicated spectra.  Relaxation 
datasets recorded at 600 and 900 MHz were validated using self-consistency tests within 
relax (See Supplementary Figure 3). Extended model free analysis (11-13) was performed 
within relax 1.3.9 which involved AIC model-free model selection (14) and elimination of 
failed models followed by Monte Carlo simulations (15). After initial calculation of local τm 
values, isotropic (sphere) and anisotropic (prolate/oblate spheroids, ellipsoid) diffusion 
models were optimised followed by AIC selection of the best model. 
Expression, purification and crystal structure of domain 11AB5-RHH 
Domain 11AB5 Q1569R P1597H S1602H pET 26a plasmid was generated and refolded as 
above. Protein concentration of 2.5 mg/ml (160 µM) was used to screen for crystals in a 96 
well format using Phoenix Liquid Handling System (Art Robbins Instruments) with multiple 
commercial buffer screens. Crystals corresponding to data collection were formed in JCSG-
plusTM screen, well G11 (2.0 M Ammonium Sulphate, 0.1M Bis-(2-hydroxyethyl)imino-
tris(hydroxymethyl methane, pH 7.0), to generate orthorhombic crystals (width:5 µm, length: 
40 µM). Data collection carried out using PILATUS detector at station I04 of the Diamond 
synchrotron revealed that crystals were orthorhombic and belonged to space group P212121.  
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Diffraction images were processed using automated Xia 2 pipeline at Diamond Light Source, 
UK.  Auto processed data generated from Xia 2 yielded intensity data to medium resolution 
(for data statistics, molecular replacement and refinement details, see Supplementary Table 8).  
SPR validation and binding analysis.   
Kinetic analysis of mutants by SPR was conducted using a Biacore T200 biosensor at 
25 ºC in either HBS-EP or MES-EP (20 mM MES pH 6.5, 150 mM NaCl, 3 mM EDTA, and 
0.005% (v/v) surfactant P20) at a flow-rate of 40 µL min-1. For analysis of the domain 
11:IGF2 interaction, approximately 20-50 RU of biotinylated IGF2 (GroPep, Aus) or IGF1 
were immobilized on a CM5 chip by affinity capture to streptavidin and domain 11 at 
concentrations ranging from 64 nM to 0.125 nM. For the analysis of the Fc-domain 11AB5 
interaction, approximately 50 RU of a biotinylated IGF2:biotinylated ubiquitin mixture (1:8 
proportion) was immobilised on the CM5-streptavidin chip. Alternatively, Fc-domain 11AB5 
and Fc-domain 11AB5-RHH (or Fc-domain 11I1572A as control) were immobilised by antibody 
capture (GE Healthcare) with and without human IgG1 Fc fragment (Bethyl Laboratories, 
UK) in the control flow cell.  Concentrations of IGF21-67, proIGF21-104, proIGF21-156 and 
IGF1 ranging from 0.125 to 32 nM were injected. T200 BiaEvaluation software (GE 
Healthcare) was used to fit the resulting curves according to a 1:1 binding model. 
Thermodynamic data was performed across the temperature range of 10 ºC to 30 ºC, van’t 
Hoff and Erying plots generated and ΔH, -TΔS and ΔG values determined as previously 
described (4). 
Fc-fusion protein expression and purification.  
IgG1 Fc-domain 11AB5 fusion protein was first cloned as previously described (16), 
produced by transient transfection of HEK293T cells with pHLSec-AB5-hIgG1 and utilising 
Corning Cellstack10’s to scale-up cell culture (Supplementary Fig. 7). Bulk production was 
performed in Chinese Hamster Ovary cells GS knockout (CHOK1SV GS-KO cells, Lonza 
Biologics, PLC). Prior evaluation of in silico antigenicity utilised EpibaseTM HLA class II 
allotypes against amino acid sequences of Fc constructs, including linkers, showed that 
domain 11AB5 was less antigenic domain 11AB5 and so was selected for bulk production.  Bulk 
cultures from stable selected CHOK1SV GS-KO resulted in protein A affinity purified yields 
in the range of 27 to 187 mg/L.  SDS-Page and size exclusion HPLC confirmed a single Fc 
product with endotoxin levels < 0.74 EU/mg.  For Fc-domain11AB5:IGF2 co-precipitation, an 
aliquot of 400 µL of media of cells treated with Fc-domain11AB5 or Fc-domain11I1572A or a 
previously incubated mixture of recombinant IGF2 and Fc-domain11AB5 was incubated 
overnight at 4 ºC with Protein A/G Agarose (Immuno-precipitation, Protein A, Roche). 
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Agarose beads were washed according to the manufacturer´s instructions, resuspended in 2 × 
sample buffer, boiled and the supernatant used for western blot analysis as described 
previously. 
IGF2 induced hypoglycaemia.  
All animal experiments were approved by the animal use ethical committee of Oxford 
University and fully complied with UK Home Office guidelines (PPL 30/2695). Wild-type 
C57BL/6J and 129S2 mice were anaesthetised using a rising concentration of isoflurane in 
oxygenated air and maintained using 2% isoflurane with 2 L min-1 oxygen.  Blood glucose 
measurements were taken using an Advantage diabetic glucose meter (Roche Diagnostics, 
UK), blood glucose levels were allowed to normalise for 30 min prior to taking a baseline 
blood glucose reading, then either 1 mg kg-1 IGF2 alone (R&D systems), or 1 mg kg-1 IGF2 
premixed with 10.9-11.7 mg kg-1 Fc-domain 11AB5, Fc-domain 11AB5-RHH or Fc-domain 
11I1572A (for a 1:1 molar ratio) were injected.  Blood glucose measurements were taken every 
10 min for the following hour. For the Fc-domain 11AB5 mouse preloading experiment, 11.7 
mg kg-1 Fc-domain 11AB5 or PBS, as negative control, were injected immediately after 
induction of anaesthesia, 30 mins later a baseline blood glucose determined and IGF2 (1:1 
molar ratio) injected, readings were then taken every 10 min for the following hour. For the 
IGF2 preloading experiment, 1 mg kg-1 IGF2 was injected immediately after induction of 
anaesthesia, 30 min later a baseline blood glucose reading was determined and either 11.7 mg 
kg-1 Fc-domain 11AB5 (1:1 molar ratio) or PBS were injected, readings were then taken every 
10 min for the following hour. 
IGF2 dependent human cancer cell xenografts.   
IGF2 sensitive autocrine cell lines SKNMC-IGF21-67, SKNMC-FLAG-IGF21-67, 
SKNMC-IGF21-104and SKNMC-FLAG-IGF21-104 were generated from the Ewing sarcoma 
cell line SKNMC by retroviral infection with constructs containing IRES-luciferase. 
Constructs were generated by cloning into the the BglII and EcoRI of the pMSCV retroviral 
expression vector.  The constructs contained the IGF2 secretion signal, followed by the IGF2 
(e.g. with and without the FLAG-tag and R67STOP/ R104STOP truncated coding sequence) 
IRES and the Luc2 gene. Retrovirus were packaged by transfection of constructs with 
TransIT-X2 (Mirus) into Phoenix cells, medium was collected after 48 h, filtered (0.45 µm) 
and replaced the medium of SKNMC cells with polybrene (6-8 µg/ml). After 48hr, the 
transfection medium was removed from target cells and transduced cells were selected with 
fresh medium containing 2 µg/ml of puromycin. 
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Autocrine growth and signaling function of SKNMC lines, including inhibition by 
IGF2-TRAP, were confirmed in culture using an MTS reagent (Cell Titer 96 Aqueous One 
Solution cell proliferation assay, Promega).  For xenografts, approximately 5x106 SKNMC-
IGF21-67 cells harvested during the growth phase of sub-confluent cell cultures were then 
mixed with matrigel (50:50 v/v, 100µl/ mouse) and injected (sub-cutaneous) into CD-1® 
(Crl:NU-1 Foxn1nu) female mice, 24 hours after establishing ALZET® mini-pump placement 
delivering a single concentration 40mg kg-1 per week either IGF2-TRAP or PBS vehicle 
control.  Tumour growth was monitored with both caliper measurements and 
bioluminescence.  The latter was performed with a Bruker Xtreme 2D optical system 15 
minutes (10 second exposure) following luciferin injection (100 µl per 20g body weight).  
Tumours were excised at 28 days or when size was > 1000 mm3. Fixation in formalin, 
embedding in paraffin and Hematoxylin and Eosin (H&E) staining was done using standard 
protocols. Apoptotic area was quantified using automated image analysis of brightfield 
images in ImageJ, applying H AEC color de-convolution filter and automated thresholding.  
Serum was also collected at the time of culling.  
IGF2-TRAP synthetic lethality screens.  
For synthetic lethality screens (Target Discovery Institute, University of Oxford), 
either 2,500 or 5,000 SKNMC-IGF21-104-IRES-luc cells were plated in medium containing 
0.5% charcoal stripped FBS in 384 well plates and the IGF2-TRAP was added 24h later to 
half of the plates. Using automated dispensing, 307 oncology drugs that have been tested in 
man (TDI expanded OncologyDrug library) were added to cells 3hrs later at 10 µM, 1 µM, 
100 nM and 10 nM, in the presence and absence of 250 nM IGF2-TRAP. After 48hr of 
incubation, resazurin was added to a final concentration of 10 µg/mL and the fluorescence 
(Ex: 560 nm, Em: 590 nm) recorded at 2hr.  Normalisation was performed with untreated 
cells and cells treated with the fixed concentration of IGF2-TRAP alone.  Pearson’s product-
moment correlation coefficient (r) was calculated to determine replicate correlation.  For hit 
selection, we used a bespoke ‘interaction score’ metric (a variation on standard ∆z-score 
analysis) followed by hit selection using the robust non-parametric Rank Product method (17).   
The interaction score was calculated where ! was the viability readout for the drug 
condition, ! was the sample mean of the negative controls and ! was the sample standard 
deviation of the negative controls, ! was calculated as !!"#$!%#&! = (! − !)/!. !!"_!" was 
calculated from PBS control plates, comparing ‘drug d’ to same- plate negative controls ‘cells 
+ DMSO’. !!" was calculated from treated plates, comparing ‘drug d + IGF2-TRAP (IT)’ to 
same-plate negative controls ‘cells + IT + DMSO’. The magnitude of these z-scores reflects 
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the degree of inhibition of cell viability by ‘drug d ± IT’ relative to negative controls, also 
taking into account well-to-well variation. The interaction score is defined as !!"_!" − !!".                                  
Thus, a more negative interaction score represents a greater synergistic lethal effect: the 
inhibitory effect of the drug is potentiated by IT. Interaction scores were calculated for each 
replicate !!,!/!!,!/!!,!!independently.  
The rank product was calculated in each data set (16 data sets: cell density x drug 
library concentration x rezasurin incubation time) each replicate for each drug was ranked 
independently, with 1st rank assigned to the most negative interaction score. Using these 
ranks, a Rank Product!!" !  for drug d in each data set was calculated, where !!,! is the rank 
of the ith replicate for drug !: !" ! = !!,! !!,! !!,!!  
In a permutation test, the RP for each drug is compared to a simulated data set giving an 
estimated p-value of false positive. These p values, in the context of our experiment, 
informed us about effect size, direction and reliability, and allowed us to control the false 
discovery rate in contrast to many other hit selection protocols43. Hits were selected where 
p<0.05. 
For synthetic lethality hit validation, fresh stocks of the two drugs selected as hits 
were obtained (pictilisib, SYNkinase and PF-04691502, Cayman Chemical). The interaction 
of the selected drugs and IGF2-TRAP were evaluated by Q-value calculated by the formula 
Q=FD+T/FD+(1-FD)FT, where FD+T represents the fraction affected by treatment with the drug 
plus IGF2-TRAP compared with the untreated control group, FD represents the fraction 
affected by the drug alone, and FT represents the fraction affected by the IGF2-TRAP alone. 
A value of Q>1.15 indicates a synergistic effect, Q<0.85 indicates an antagonistic effect, 
and Q between 0.85 and 1.15 indicates an additive effect (18). 
In addition to the screen protocol, we used cell lines SKNMC-IGF21-67-IRES-luc and 
Ewing’s line ST-A-ET1 (ATCC) and a tailored dose range for each drug (Supplementary 
Figure 11).  Standard curve fit used: log (inhibitor) vs. response (three parameters) with 
constant slope = -1.0. R2 value for goodness-of-fit and IC50 values with 95% confidence 
intervals. Error bars indicate s.e.m. Drug concentration of zero is shown on log dose plots as 
~2 logs below the next lowest dose.  Prism 6 software was used for all statistical analysis 
apart from hit selection.  
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Cell assays, protein extraction and Immunoblotting. 
For analysis of IGF2 secretion by the different cell lines, cells were plated in 6-well plates in 
serum-free medium at a concentration of approximately 106 cells per well. The medium was 
collected after 48 hr, spun at 4000g for 20 min and the supernatant filtered through a 0.22 µm 
filter. For signaling analysis, cells were plated in 6-well plates at a concentration of 
approximately 3-6x105 cells per well in serum-free medium. After 24 hr, Fc-domain11AB5/AB5-
RHH (or PBS and Fc-domain 11I1572 as negative controls) were added to each well to the 
corresponding concentration and the cells were incubated for further 48-72 hr. Cells were 
washed with PBS and lysed on ice in RIPA buffer (50mM Tris HCl pH 8, 150 mM NaCl, 1% 
NP-40, 0.5% sodium deoxycholate, 0.1% SDS) containing protease and phosphatase 
inhibitors (Halt cocktail, Pierce). Lysates were cleared by centrifugation at 4°C. Protein levels 
were quantified using the CB-X assay (G-Biosciences) as per manufacturer’s instructions. 
SDS-PAGE gel electrophoresis and protein transfer of either 20 µg of protein or 5 µL of 
serum were done following standard protocols. Antibodies used were anti hIGF2 (R&D 
Systems AF-292, 2 µg mL-1), anti pAktS473 (Cell Signaling 4060, 1:1000), anti β-actin 
(AbCam 8227, 1:20000), anti pIGF1RY1135/1136/pIRY1150/1151 (Cell Signaling 3024, 1:1000), 
CaptureSelect Biotin Anti-hIgG-Fc (Life Technologies, 1:1000), anti mIGF1 (R&D Systems 
AF-791, 1 µg mL-1), anti mIGFBP2 (Millipore 06-107, 1/1000 dilution), anti mIGFBP3 
(R&D Systems MAB775, 1 µg mL-1), anti mIGFBP5 (R&D Systems AF578, 0.1 µg mL-1), 
anti mIGFBP6 (R&D Systems AF776, 0.1 µg mL-1), anti mGH (R&D Systems BAF1566, 0.5 
µg mL-1), anti hIGFBP3 (Santa Cruz Biotechnology Sc-9028, 1 µg mL-1), anti hALS (Novus 
Biologicals NBP1-89118, 1 µg mL-1). Secondary antibodies were from Dako, used at 1:2000, 
except Streptavidin HRP at 1:4000 (Thermo Scientific Pierce). Densitometry was performed 
using ImageJ (NIH) and was normalized to actin.  








Supplmentary Table 1 
Loop libraries. Mutated residues in each loop are shown in bold, Sequences of the forward and 
reverse oligonucleotide primer pairs used for site-directed mutagenesis to generate domain 11 loop 
specific libraries are shown. One oligo in each pair was 5’-phosphorylated (indicated with *). XXX 





Sequence Oligonucleotide Sequence (5’ to 3’) 
Number of 
possible variants 
AB YSKKGL NNK NNK NNK GTT TAC ATG AGC ATC TGT GGG GAG 3.2 x106 *CTT MNN MNN AGC AGC TGT GAA TCC CGC CC 
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Supplementary Table 2.  Affinity kinetics of AB loop mutagenesis to identify domain 11AB5 and 
site directed mutants following structural predictions.  SPR binding analysis of recombinant 
M6P/IGF2R domain 11 mutants interaction with IGF2. kon indicates association (on) rate; koff, 
dissociation (off) rate; RU, response units. Binding to IGF2 assessed with BIAcore T200 using 
purified biotinylated IGF2 and IGF1 on a streptavidin biosensor chip. Recombinant proteins were 
expressed either in E. coli and/or P. pastoris. All the mutants in the FG and HI loops are on the 
domain 11AB5 background for the AB loop unless otherwise stated. All experiments were carried out 
at 25 ºC in HBS-EP buffer (pH 7.4) and repeated 2-5 times on two independent BIAcore chips. nd = 






























 WT 46±1.8 5.0 0.23 0.33 64±1.0 0.24 
AB 
AB3 15.3±2.0 2.76 0.044 0.41 15.5±3.3 0.77 
AB5 5.07±0.87 4.21 0.0208 0.87 6.44±1.06 0.14 
W1546F 4.35±0.49 4.5 0.0180 0.767 5.00±0.93 0.129 
FG 
P1599A* >70 Nd >0.1 - >70 - 
P1599V* >100 Nd >0.1 - >100 - 
P1599G* >200 Nd >0.2 - >200 - 
S1600A 89.10±5.1 2.39 0.2126 nd 84.65±15.20 0.04 
S1600V >200 Nd >0.2 nd >200 - 
S1600L >200 Nd >0.2 nd >200 - 
S1600Y >200 Nd >0.2 nd >200 - 
S1600N 24.44±8.70 3.95 0.0910 0.15 29.67±9.54 0.01 
K1601A 6.80±0.65 3.26 0.0220 0.51 8.51±0.39 0.04 
K1601R 4.75±0.08 5.28 0.0251 0.37 5.78±0.18 0.07 
S1602A 16.48±3.83 1.57 0.0250 0.63 19.92±3.77 0.17 
S1602H 3.19±1.00 3.61 0.0112 1.24 5.44±1.41 0.96 
S1602N 4.75±0.52 2.38 0.0112 0.56 7.93±2.29 0.46 
S1602Q 3.61±1.19 5.88 0.0191 0.57 5.11±0.73 0.13 
G1603A 8.69±1.48 2.14 0.0183 0.45 12.09±0.69 0.16 
G1603K 2.73±0.95 4.66 0.0121 1.18 4.54±0.91 1.18 
L1604A 48.34±8.4 0.79 0.0397 0.26 59.96±19.8 0.01 
HI 
K1631A >200 - - - >200 - 
K1631R 12.29±2.81 7.18 0.0867 0.23 13.51±2.65 0.08 
K1631E >100 - >0.1 - >100 - 
K1631W 2.94±0.37 1.18 0.0034 1.47 12.16±2.35 3.16 
Q1632A 3.76±0.54 4.50 0.0167 0.57 4.84±0.22 0.12 
Q1632K 11.07±2.10 1.96 0.0212 0.34 12.84±0.63 0.05 
Q1632E 39.83±7.10 0.52 0.0202 2.11 52.41±4.29 0.06 
Q1632L 5.75 ±1.05 3.18 0.0175 1.17 9.34±1.69 2.00 
T1633A 26.41±9.49 0.80 0.0196 0.21 53.55±10.0 0.19 
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Supplementary Table 3.  
Affinity kinetics of Domain 11AB3 spontaneous mutants and HI Loop mutagenesis library 
directed screen.  
 
Mutant Domain 11 

























WT 46±1.8 5.0 0.23 0.33 64±1.0 0.24 
AB3 15.3±2.0 2.76 0.044 0.41 15.5±3.3 0.77 
AB3 + 62B (FG-P1597H) 1.23±0.32 10.6 0.013 1.62 1.76±0.47 1.43 
AB3 + 73E (CD-Q1569R) 2.30±0.27 13.6 0.031 1.54 3.15±0.41 0.25 
WT + 23D (HI-HFQS)* 176 0.25 0.065 0.56 220.5 0.45 
WT + 26C (HI-DMQT)* 130 1.89 0.24 0.17 127 0.19 
WT + 27G (HI-NMAL)* 195 2.0 0.25 0.19 194 0.13 
WT+ 312G (HI-VKLM)* 119 1.07 0.15 0.27 135 0.45 
AB5 + 51F (HI-NRQS)* 13.5 7.4 0.10 0.31 6.94 0.26 
*Protein quality poor based on absorption spectra 
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Supplementary Table 4 
NMR structural data for domain11WT, domain 11AB5 and domain 11AB5:IGF2 complex 
Restraints, energies, RMSD values and number of NOE violations for the ensemble of twenty 
structures for each protein.  All values calculated by ARIA(19) , with the exception of NOE restraint 
distribution, which was calculated using the countNOE.py script provided by Benjamin Bardiaux 
(Institut Pasteur, Paris).  *RMSD to mean values were calculated for residues in the secondary 
structure. 
 





Total NOE restraints 2200 2168 3176 
Intraresidue NOEs 800 871 1242 
Sequential/short/medium NOEs 
(residue i to i+1, 2, 3, 4, 5) 746 718 1158 
Long-range NOEs 654 446 776 
Dihedral angle restraints 
Backbone φ and ψ 206 211 249 
Hydrogen bond restraints 60 48 52 
Energies (kcal mol-1) 
ENOE 3.3 ± 0.4 4.2 ± 1.8 7.0 ± 0.6 
EVDW -567 ± 21 -1187 ± 13 -1226 ± 12 
EELEC -5531 ± 74 -5117 ± 98 -5064 ± 69 
RMSD from ideal geometry 
Bonds (Å) 0.0048 ± 0.0001 0.0101 ± 0.0002 0.0105 ± 0.0002 
Angles (°) 0.58 ± 0.01 1.03 ± 0.03 1.07 ± 0.02 
Improper (°) 0.57 ± 0.02 1.26 ± 0.07 1.36 ± 0.07 
RMSD to mean for backbone 
atoms* 0.54 ± 0.12 0.55 ± 0.10 0.27 ± 0.04 
RMSD to mean for heavy atoms* 1.52 ± 0.22 0.99 ±0.10 0.56 ± 0.04 
Average number of NOE violations 
>0.1 Å (per structure) 121 1 0.1 
>0.3 Å (per structure) 11 0 0 
>0.5 Å (per structure) 0 0 0 
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Supplementary Table 5 
 
Structure quality statistics for domain11WT, domain 11AB5 and domain 11AB5:IGF2 complex 
 
Ramachandran plot regions and iCing Z-scores for the lowest energy structure and ensemble for 
domain 11WT, domain 11AB5 and its complex with IGF2.  Structure Z-scores above zero are better than 
average.  RMS Z-scores should be close to 1.  Human ensemble results were recalculated using NRG-





For ensembles of 20 
structures 
Domain 11WT Domain 11AB5 Domain 11
AB5:IGF2 
Complex 
Best Ensemble Best Ensemble Best Ensemble 
Ramachandran plot       
Most favoured (%) 78.3 77.7 80.5 80.6 76.3 77.0 
Additionally allowed (%) 17.4 17.9 18.6 18.2 22.0 22.1 
Generously allowed (%) 3.4 3.5 0.8 0.6 1.7 0.8 
Disallowed (%) 0.9 0.9 0.0 0.6 0.0 0.1 
Structure Z-scores       
1st generation packing -0.54 1.76 ± 0.62 -0.51 2.24 ± 0.81 -0.54 2.23 ± 0.59 
2nd generation packing -1.63 7.59 ± 2.20 -0.79 7.41 ± 2.15 0.95 7.41 ± 2.03 
Ramachandran plot -5.04 -4.24 ± 0.23 -2.85 -2.87 ± 0.43 -3.96 -3.92 ± 0.33 
χ1 – χ2 rotamer normality -3.45 -3.70 ± 0.44 -0.74 -1.38 ± 0.55 -2.67 -2.62 ± 0.40 
Backbone conformation -3.47 1.56 ± 0.22 -0.61 -0.94 ± 0.29 -1.46 1.47 ± 0.15 
RMS Z-scores       
Bond lengths 1.28 1.28 ± 0.02 1.11 1.11 ± 0.01 1.12 1.12 ± 0.01 
Bond angles 0.64 0.64 ± 0.02 0.46 0.46 ± 0.01 0.46 0.47 ± 0.01 
ω angles 0.17 0.91 ± 0.05 0.56 0.58 ± 0.04 0.67 0.63 ± 0.03 
Side-chain planarity 0.85 0.85 ± 0.10 0.63 0.62 ± 0.09 0.71 0.69 ± 0.10 
Improper dihedrals 0.79 1.07 ± 0.05 0.78 0.78 ± 0.03 0.78 0.81 ± 0.02 
Inside/outside distribution 0.95 0.94 ± 0.01 0.94 0.96 ± 0.02 0.97 0.97 ± 0.01 
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Supplementary Table 6. 
Affinity kinetics of combined CD, FG and HI, loop combined mutants with AB loop 
backgrounds domain 11AB3 and domain 11AB5.  Measurements were carried out at 25oC in HBS-EP 
buffer (pH 7.4) (nd= not determined, np= no protein).  Data for KD expressed as mean of each 
experiment, and means of kon and koff  are shown. 
 
Domain 11 Mutant 















AB3 15.3±2.0 2.76 0.044 15.5±3.3 3 
AB3 Q1569R 2.30±0.27 13.6 0.031 3.15±0.41 4 
AB3 P1597H 1.23±0.32 10.6 0.013 1.76±0.47 4 
AB3 P1597K 2.78±0.61 10.5 0.0287 3.59±0.77 4 
AB3 Q1569R P1597H 0.90±0.29 18.9 0.0153 1.73±0.4 5 
AB3 Q1569R P1597K 1.34±0.47 20.0 0.0241 2.27±1.04 5 
AB3 P1597H K1631W 17.55±1.88 19.7 0.3478 18.67±2.23 5 
AB3 P1597H HI23D nd nd 0.012 nd 8 
AB3 P1597K S1602H 3.73 2.74 0.0102 5.332 5 
AB3 Q1569R P1597H S1602H 0.74±0.22 14.1 0.010 1.53±0.46 6 
AB3 Q1569R P1597K S1602H 0.79±0.25 20.1 0.016 1.39±0.48 6 
AB3 Q1569R P1597H K1631W np np np np 6 
AB3 Q1569R P1597K K1631W np np np np 6 
AB3 Q1569R P1597H S1602H G1603K 0.62±0.03 17.5 0.0108 1.31±0.16 7 
AB3 Q1569R P1597K S1602H G1603K 0.78±0.22 20.8 0.0171 1.62±0.41 7 
AB3 Q1569R P1597H S1602H K1631W np np np np 7 
AB5 5.07±0.87 4.21 0.0208 6.44±1.06 5 
AB5 Q1569R 2.24±0.44 8.04 0.0175 3.22±0.55 6 
AB5 P1597H 1.90±0.60 3.68 0.0070 2.79±0.52 6 
AB5 P1597A 9.07±1.08 1.90 0.0174 12.44±0.69 6 
AB5 P1597K 1.94±0.39 9.54 0.0120 2.21±0.14 6 
AB5 P1597L 3.86±1.68 4.18 0.0150 4.85±1.82 6 
AB5 P1597N 4.13±1.74 4.72 0.0180 5.36±2.24 6 
AB5 P1597Q 3.83±2.42 6.53 0.0203 4.51±2.66 6 
AB5 P1597S 4.19±1.80 5.00 0.0193 4.90±1.88 6 
AB5 HI23D np np 0.012 np 9 
AB5 Q1569R P1597H 1.95±0.60 3.2 0.0058 5.40±0.98 7 
AB5 Q1569R P1597K 0.95 9.59 0.0091 1.69 7 
AB5 P1597H S1602H 1.17±0.2 3.50 0.0046 2.93±0.47 7 
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AB5 P1597K S1602H 4.62 2.09 0.0096 7.85 7 
AB5 P1597H HI2-3D np np np np 10 
AB5 Q1569R P1597H S1602H 0.65±0.11 5.90 0.0038 2.0±0.50 8 
AB5 Q1569R P1597K S1602H 0.92±0.13 7.87 0.0073 2.11±0.55 8 
AB5 Q1569R P1597H G1603K 0.87±0.09 6.67 0.0058 2.01±0.30 8 
AB5 Q1569R P1597H Q1632L np np np np 8 
AB5 Q1569R P1597H K1631W 1.02±0.06 11.20 0.0115 1.95±0.47 8 
AB5 Q1569R P1597K K1631W np np np np 8 
AB5 Q1569R P1597H HI2-3D np np np np 11 
AB5 Q1569R P1597H S1602H G1603K np np 0.005 np 9 
AB5 Q1569R P1597K S1602H G1603K np np 0.008 np 9 
AB5 Q1569R P1597H S1602H K1631W np np np np 9 
AB5 Q1569R P1597K S1602H K1631W np np np np 9 
AB5 Q1569R P1597K S1602H Q1632L np np np np 9 
AB5 Q1569R P1597H S1602H G1603K  
         K1631W 
np np np np 10 
AB5 Q1569R P1597K S1602H G1603K  
         K1631W 
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Supplementary Table 7.  
pH dependent affinity kinetics of combined CD, FG and HI, loop mutants with AB loop 
backgrounds domain 11AB3 and domain 11AB5 (pH 6.5) compared to Table 6 (pH 7.4). 
Measurements were carried out at 25oC in MES-EP buffer (20 mM MES pH 6.5, 150 mM NaCl, 3 
mM EDTA, and 0.005% (v/v) surfactant P20).  Data for KD expressed as mean of each experiment, 













WT 35.06±10.45 2.68 0.1441 
AB3 11.85±0.20 3.43 0.0381 
AB3 Q1569R P1597H 0.47±0.06 19.9 0.0091 
AB3 Q1569R P1597H S1602H 0.40±0.07 16.1 0.0064 
AB3 Q1569R P1597H S1602H G1603K 0.43±0.03 24.3 0.0087 
AB5 4.38±0.78 4.17 0.0180 
AB5 Q1569R P1597H 1.46±0.29 2.37 0.0034 
AB5 Q1569R P1597H S1602H 0.71±0.10 4.41 0.0030 
AB5 P1597H S1602H 0.62±0.34 5.32 0.0029 
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Supplementary Table 8 
Crystallographic Data Statistics for Domain 11 AB5-RHH 
 
 
Data set Domain 11 AB5-RHH 2.8 Å  
   
   
Space Group P212121  
Wavelength (Å) 0.98  
High resolution Range (Å) 34.9-2.8 
Measurements 42539 
Unique Reflections 6912 
Completeness (%) 99.9 (100)a 
I/σ(I) 6.4 (1.35) 
Rmerge (%)b 22.7 (46.4) 
CC half 0.989 
Wilson B factor 26.5 
R factor (%)c 23.7  
Rfree (%)d 27.8  
R.m.s.d. from ideal   
Bonds (Å) 0.017  
Angles (°) 1.90  
Average B factors (Å)  30.5  
B factor r.m.s.d. (Å)    
main chain 1.32  
side chain 1.65  
Total number of non-hydrogen atoms   
protein 1018  
water 20  
other 2x SO!!!  
 1 x glycerol  
 1x 1,2-ethanediol  
a
Values in parentheses correspond to the highest resolution data shell (2.8 Å) 
bRmerge = Σ|I-⟨I⟩|/ Σ⟨I⟩&
c










 is as for R factor but calculated using a 5% test set of reflections excluded from the refinement. 
Data collection carried out using PILATUS detector at station I04 of the Diamond synchrotron 
revealed that crystals were orthorhombic and belonged to space group P212121.  Diffraction images 
were processed using automated Xia 2 pipeline.  Auto processed data generated from Xia 2 yielded 
intensity data to medium resolution.  Processing was carried out using programs in the CCP4 suite 
(21).  Phaser MR (22) was used in molecular replacement (MR) with a known structure (PDB:1GP0) 
for domain11WT to generate a MR solution. The crystals contained a single domain 11AB5-RHH 
monomer per crystallographic asymmetric unit; the same as 1GP0.  Structural refinement was then 
carried out using refmac5 (23).  Further refinement was undertaken, with the rebuilding of the AB 
loop from WT to AB5, the introduction of residues Q1569R, P1597H and S1602H and other manual 
rebuilding performed using COOT (24). Structural model built was then validated using PROCHECK 
(25), MolProbity (26), and PDB_REDO server (27).   





Supplementary Table 9  
Affinity of IGF2 isoforms (IGF21-67, IGF21-104 and IGF21-156) and IGF1 for the Fc-domain 
11AB5, Fc-domain 11AB5-RHH and Fc-domain 11I1572A fusion proteins. SPR analysis of the 
interaction of recombinant IGF1 and IGF2 forms with Fc-domain 11 proteins immobilised by 
antibody capture (CM5 chip containing monoclonal mouse anti-human IgG antibody 
immobilised by amine coupling). Measurements were carried out at 25oC in HBS-EP buffer 












Interaction with Fc-domain 11AB5    
IGF21-67 3.89 6.47 0.025 
IGF21-104 0.54 12.87 0.0069 
IGF21-156 0.21* 4.19* 0.0009 
IGF1 - - - 
Interaction with Fc-domain 11AB5-RHH    
IGF21-67 0.54 2.60 0.0014 
IGF21-104 0.39 1.29 0.0005 
IGF21-156 1.13* 0.23* 0.0003 
IGF1 - - - 
Interaction with Fc-domain 11I1572A    
IGF21-67 - - - 
IGF21-104 4.41 0.52 0.002 
IGF21-156 2.71* 0.29* 0.0008 
IGF1 - - - 
* Note, kinetic analysis may be inaccurate because of uncertainties in the concentration of 
recombinant IGF21-156 (Gropep).  This consisted of a mixture of three isoforms, the full-length 















Background to Supplementary Figures S1-4 
Relaxation data analysis for domain 11WT and domain 11AB5.  
 
NOE, R1 and R2 relaxation datasets were recorded for domain 11WT and domain 11AB5 
and are shown in Supplementary Fig. 2a-f. NOE ratios, which are sensitive to fast 
picosecond motions, are shown at both 600 and 900 MHz for domain 11 and domain 
11AB5 (Supplementary Fig. 1a, 1b). NOE values above 0.7 (indicating more ordered 
regions of protein structure) were generally located in β-strand secondary structure of 
the β-barrel in both proteins as previously observed for domain 11WT (5). The AB, CD, 
FG and GH loop regions and termini had lower NOE ratios indicating the presence of 
faster ns-ps motions. The most flexible loops in domain 11WT were the AB and GH 
loops with significantly reduced values seen in both.  In domain 11AB5 however, the 
AB loop NOEs does not show the same degree of reduction. Flexibility in the isolated 
domain 11WT AB and GH loops are might be expected due to removal of the 
neighbouring domain 13 that is observed to pack against it in the X-ray structure (28). 
The FG loop shows reduced NOE values in both proteins whereas the CD loop 
appears to show only marginally lower values. These differences are also reflected in 
the R1 values with domain 11AB5 showing almost uniform values across the entire 
peptide compared to domain 11WT which whose elevated R1 values across the loops 
with reduced NOE values. With the exception of the FG loop, R2 values across 
domain 11AB5 are reduced compared to the wild type human protein.  
 
Validation of domain 11WT and domain 11AB5 relaxation datasets.  
 
R1 and R2 relaxation rates were validated by calculation of 900:600MHz ratios for 
each parameter (Supplementary Fig. 2). R1 values were more consistent than R2 
values due better signal to noise in these experiments. R1(900)/R1(600) and 
R2(900)/R2(600) ratio averages (Supplementary Fig. 2a-d) and standard deviations 
were comparable between the two proteins. R1(900)/R1(600) ratios were 0.65 ± 0.07 
for human wild-type and 0.64 ± 0.05 for domain 11AB5. R2(900)/R2(600) ratios were 
1.30 ± 0.22 for domain 11 and 1.17 ± 0.29 for domain 11AB5. R2/R1 ratios were 
calculated at 600 (black) and 900 (white) MHz (Supplementary Fig. 2e-f) with lines 
marking the mean for each field. 900:600MHz ratios deviating form the average and 
yielding a non-linear correlation between R2/R1 and field strength, were excluded 
from subsequent Lipari-Szabo model-free calculations. An average of the three 
consistency test results is shown for domain 11WT (Supplementary Fig. 2g) and 
domain 11AB5 (Supplementary Fig. 2h). For all tests, a parameter ratio 900/600 MHz 
close to 1 represented data which was consistent between fields. Results were more 
consistent for domain 11 (0.98 ± 0.21) versus 1.07 ± 0.16 for domain 11AB5. Fη, FR2 
(29) and J(0) (30)consistency tests provided with RELAX used NOE ratio, and R1 and 
R2 relaxation rates (31) are shown in Supplementary Fig. 3a-l. Distributions (panels d-
f for domain 11 versus j-l for domain 11AB5) for both proteins are within a range of 
values previously described (31-33). Any values that severely deviated from a 
900:600MHz ratio of 1 were removed before input of parameters into relax for 
application of the Lipari-Szabo model-free formalism. 
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Lipari-Szabo model-free calculations for domain 11WT and domain 11AB5. 
 
Lipari-Szabo parameters for isotropic (spherical) and anisotropic models (oblate, 
prolate and ellipsoid) were best fit in RELAX by oblate and fully anisotropic models 
for domain 11WT and domain 11AB5 respectively.  Residues that passed internal 
consistency tests were used in the calculation of the global rotational correlation time 
that was determined to be 7.62 ns for domain 11WT and 8.19 ns for domain 11AB5. 
This is consistent with a negligible effect on the oligomeric state of the protein and 
the overall tumbling rate in solution. Residues were fit to one of five models. These 
included model 1, where the backbone motion could be described by the generalized 
order parameter S2 only, model 2 that incorporates S2 and a contribution from faster 
picosecond motions characterized by a second correlation time τe (S2 - τe) and models 
3 and 4 that incorporate an additional slower (typically µs-ms) exchange contribution 
(Rex) and described by S2 - τe and S2 - τe - Rex respectively. Fits to these models are 
shown in Supplementary Fig. 4a-c. Domain 11 WT flexible AB, BC and CD loops, 
shown by S2 values below 0.7. These loop regions are much more rigid in domain 
11AB5, consistent with NOE, R1 and R2 data. This suggests that the ring-stacking 
interactions of Y1542, W1546 and F1567 could reduce flexibility in the AB, BC and 
CD loops, stabilising the docking site of IGF2. Internal correlation times (τe) also 
reveal values of ~ 1ns that are present in the β-cap, pre-AB loop strand, AB, CD, FG 
and GH loops of domain 11 WT that are not observed in domain 11AB5. Similarly 
greater contributions from slower exchange are observed in the β-cap, AB, BC, CD, 
FG and GH loops in domain 11 WT. In domain 11AB5 these again appear to be lost with 
the exception of the FG loop, which is unaffected.  
 
Residues that could not be defined by these simpler models were also fitted to a two-
time-scale model (34), an extension of the original Lipari-Szabo formalism that 
incorporates both fast picosecond (S2f, τf) and slow, sub-nanosecond (S2s, τs where S2= 
S2f S2f) contributions to the overall correlation function for the amide bond vector. S2f, 
S2f, τf, τs, parameters are shown in Supplementary Fig. 4d-g. Residues 1539-1541 and 
1547 in domain 11 display lower S2f values, mirroring the reduction in S2 seen in the 
AB loop whereas residues 1544-1546 instead show lower S2s values which still 
indicates flexibility but on a slower timescale and may reflect their proximity, and 
packing, against the the more rigid CD loop. In domain 11AB5 both fast and slow 
motions are lost in the AB loop emphasizing the importance of the G1546Q mutation 
in stabilizing the binding site of this mutant.  
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Supplementary Figure S1.  
Relaxation data for human domain 11WT and domain 11AB5. Relaxation rates for 600 
(black) and 900 and MHz magnetic field strengths are shown (red) are shown. (a) and (b) 
show NOE ratios for domain 11WT and domain 11AB5 respectively. (c) and (d) show R1 (s-1) 
and (e) and (f) show R2 (s-1) for domain 11WT and domain 11AB5 respectively. 
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Supplementary Figure S2. 
Consistency tests for human domain 11WT and domain 11AB5 relaxation datasets. 
(a) and (b) R1 and (c) and (d) R2 (900/600 MHz), (e) and (f) R2/R1 values at two 
magnetic field strengths with black (600 MHz) and white (900 MHz) circles for 
domain 11WT and domain 11AB5. (g) and (h) Consistency test averages for human 
domain 11WT and domain 11AB5 where values nearer 1 are more consistent between 
fields (y = 1 is plotted). Averages and standard deviations are shown in the top right 
corner of each graph (averages are also plotted in the top three panels). 
 




Supplementary Figure S3. 
 
Fη , FR2 and J(0) validation scores for domain 11WT and domain 11AB5 . Fη, FR2 
and J(0) validation graphs for domain 11WT (a-f) and domain 11AB5  (g-l).  Rows 1 
and 3 show individual results for each test where for each residue, the result at 600 (x 
axis) and 900 (y axis) MHz is correlated, with most consistent residues along the x=y 
line. Rows 2 and 4 show distribution of data with average value (closer to 1 is more 








Supplementary Figure S4. 
Lipari-Szabo model-free parameters for domain 11WT and domain 11AB5. Graphs 
showing (a) S2, (b) Rex and (c) τe Lipari-Szabo parameters for domain 11WT (black) 
and domain 11AB5 (white) domain 11 are plotted with respect to residue number. The 
parameters derived from a two-time scale model (34), (d) S2f, (e) S2s, (f) τf, and (g) τs 




Functional evolution of IGF2:IGF2R domain 11 
 
 28 
Supplementary Figure S5. 
Interaction maps showing the evolution of domain 11 IGF2 binding site residues. 
(a) Interaction map showing the evolution of hydrophobic binding residues on IGF2 
(centre) and binding partners (dark blue, indicating favorable hydrophobic 
interactions) over the AB, CD, FG and HI loops (clockwise).  Incorrect charge or 
polar complementarity is shown in red. Yellow represents where either the acquisition 
of a charge, or change in steric bulk of a residue, cannot be assessed in the absence of 
a high-resolution structure of the full complex. (b) Complementarity of the non-
hydrophobic groups (charged, polar and hydrogen bond interactions) of IGF2 and 
domain 11 mutants (colors as in a.) 
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Supplementary Figure S6.  
 
Comparison of thermodynamic parameters for domain 11 mutants and 
combinations. Surface plasmon resonance was performed with domain 11 mutants 
and immobilised IGF2 over a range of temperatures (10 °C to  30 °C), van’t Hoff and 
Erying plots generated and ΔH, -TΔS and ΔG values determined.  Plots of ΔH, -TΔS 
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Supplementary Figure S7. 
 










(a) HEK293T cells were grown in DMEM (10 % FCS and Penicillin/Streptomycin) in 
a 10L CellStack, transfected with polyethyleneimine (PEI) stock (1 mg/ml, pH 8.0; 
branched 25kDa PEI, Sigma-Aldrich) with gentle mixing. Following incubation for 4 
days, cell supernatant was harvested, clarified by centrifugation (8000g for 30min at 
4 °C) and filtration through a 0.45 µM membrane (type HAWP, Millipore) using a 
vacuum pump and bottle-top filtration unit (Nalgene). Purification was in two stages; 
initial capture by affinity chromatography followed by ion exchange. Capture was by 
HiTrap rProtein A FF column (GE Healthcare) pre-equilibrated with 20 mM sodium 
phosphate pH 7.0 and elution was with 0.1 M sodium citrate pH 3.5 with 
neutralisation by 0.1 volumes of 1 M Tris pH 9.0.  Cation exchange was with a 
MonoS 5/50GL column (GE Healthcare) pre-equilibrated with 50 mM sodium 
phosphate pH 7.4 and elution by steep sodium chloride gradient (left panel).  Size 
Exclusion Chromatography was performed with a Superose 6 10/300GL analytical 
column, pre-equilibrated with 150 mM sodium chloride 50 mM sodium phosphate pH 
7.0  (right panel). (b) Purity and specificity were assessed by SDS-PAGE followed by 
Coomassie staining or western blotting utilising HRP-conjugated anti-Fc antibody 
(goat polyclonal; Sigma-Aldrich) or HRP-conjugated anti-His tag antibody (Clone 
BMG-His-1; Roche) as probes. (c)  Stable CHOK1SV GS-KO cells were cultured 
(Lonza proprietary media, 4-10L) in a shaking incubator (140rpm) as described in 
material and methods.  After 7 days, clarified supernatant was purified using a HiTrap 
MabSelect SuRe column (GE Healthcare), washed and protein eluted with 10mM 
formate, pH 3.5, and neutrolised with sodium hydroxide.  SE-HPLC of the protein 
(shown) was with a Zorbax GF-250 column (Agilent).(d)  Western blot analysis of the 
purified Fc-domain 11AB5 RHH protein (lane 2, non reduced, lane 3 reduced) and IgG 
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Supplementary Figure S8.  
In vivo effect of Fc-domain 11 I1572A (null) (control) as an IGF2 antagonist in an 
IGF2-induced hypoglycaemia mouse model. Following anesthesia and 
normalisation of blood glucose levels, either 1 mg kg-1 IGF2 alone (circles, n=4), or 1 
mg kg-1 IGF2 premixed with Fc-domain 11I1572A (null) (1:1) (squares, n=3) were 
injected and blood glucose levels monitored. Premixing human IGF2 with Fc-domain 
11I1572A does not prevent IGF2-induced hypoglycaemia. 2 way ANOVA with 
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Supplementary Figure S9.  
Fc-domain 11AB5 abrogates an IGF21-67-induced hypoglycaemia in a mouse 
model.  (a) Fc-domain 11AB5 (n=4) or PBS (n=3) were injected 30 mins prior to 1 mg 
kg-1 IGF21-67. Preloading of Fc-domain 11AB5 abolished the blood glucose decrease 
caused by subsequent administration of IGF2 (p=0.0358). (b) 1 mg kg-1 IGF21-67 was 
pre-loaded and after 30 min either PBS (n=3) or Fc-domain 11AB5 (n=3) were 
administered, with the later reverting the blood glucose levels towards more positive 






























Supplementary Figure S10. 
Effect of Fc-domain 11AB5 on cell signaling in hepatocellular carcinoma cell lines. 
The human hepatocellular carcinoma cell lines Hep 3B2.1-7 and Huh-7D12 were 
obtained from the ATCC (HB-8065) and the ECACC (Catalogue number 01042712), 
respectively. Hep 3B2.1-7 was grown in EMEM (Lonza) supplemented with 10% (v/v) 
fetal bovine serum, 100 U mL-1 penicillin, 100 µg mL-1 streptomycin, and 2mM L-
glutamine Huh-7D12 was grown in DMEM (Sigma) supplemented with 10% fetal 
bovine serum, 100 U mL-1 penicillin, 100 µg mL-1 streptomycin, and 2mM L-
glutamine.  The western blot analysis of the effect on the IGF2-TRAP on the IGF2 
signaling pathway of both cell lines shows that treatment with the IGF2-TRAP 
inhibits IGF2-dependent phosphorylation IGF1R/IR-A. Fc-domain 11I1572A and OSI-
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Supplementary Figure S11. 
Effect of Fc-domain 11AB5 on cell viability, proliferation and apoptosis in 




In vitro cell viability.  Cells were plated in 96-well plates at a density of 1-2 x104 
cells/well in serum free medium. After 24 hr, Fc-domain 11AB5 (FcAB5, orange), Fc-
domain 11I1572A (FcNull, grey) as negative control or OSI-906 (purple) were added to 
each well to different final concentrations and the cells were incubated for further 48-
72 hr. Cell viability was assayed at 48 and 72 hr after Fc-domain 11AB5 treatment 
using the CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay 
(Promega). The half maximal inhibitory concentration (IC50) was calculated using 
graph prism. 
Cell proliferation assay. EdU incorporation was used to measure cell proliferation 
(Invitrogen, C10338). Briefly, cells were plated at a density of 2x105 cells/well in 6-
well plates and cultured in serum free media. After 24 hr of serum starvation, PBS 
(black) and 1.5 µM Fc-domain 11I1572 (grey) as negative controls, 0.5 and 1.5 µM Fc-
domain 11AB5 (orange), 1 µM OSI-906 (purple) and 0.1 and 0.5 µM doxocycline 
(green) as positive controls were added to the different wells and cells were further 
cultured. After 48 hr, 10 µM EdU was added for 3 hr and cells were then washed and 
trypsinised, followed by fixation in 4% PFA and permeabilisation in TBS/5% Triton. 
The Alexa 555 dye was then attached to the EdU molecules by click chemistry 
following the manufacturer’s instructions and the % of EdU incorporation under 
different conditions was then analysed by flow cytometry. 
Apoptosis assay. Cells were plated in 96-well plates at a density of 1-2 x104 
cells/well in serum free medium. After 24 hr, PBS (black) and 1.5 µM Fc-domain 
11I1572 (grey) as negative controls, 0.5 and 1.5 µM Fc-domain 11AB5 (orange), 1 µM 
OSI-906 (purple) and 0.1 and 0.5 µM doxocycline (green) as positive controls were 
added to different wells. Caspase 3 and 7 activation was assayed at 48 hr after Fc-
domain 11AB5 treatment using the Caspase-Glo®3/7 Assay (Promega). 
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Supplementary Figure S12. 
Effect of the IGF2-TRAP on cell signaling and viability of SKNMC-IGF21-67. (a) 
IGF2-TRAP decreases the cell viability of IGF2-autocrine SKNMC-IGF21-67 cell line 
compared to luciferase only SKNMC control. (b) Western blot analysis of the effect 
on the IGF2-TRAP on the IGF2 signaling pathway of the SKNMC-IGF21-67 cell line 
shows that treatment with the IGF2-TRAP inhibits IGF2-dependent phosphorylation 
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Supplementary Figure S13 
Tumour xenografts of Ewing sarcoma cell lines expressing autocrine IGF2 
(SKNMC-lucifierase-IGF267) exhibit reduce growth rates and necrosis with 
IGF2-TRAP (Fc-domain 11AB5-RHH). (a) Growth rate constant (K) of xenografts 
derived from SKNMC-IGF21-67 cell line is slower in mice receiving the IGF2-TRAP 
24 hrs prior to cell implantation, as a single infused concentration of 40 mg kg-1 per 
week over 4 weeks (p=0.036, Mann Whitney test). (b) The area of the apoptosis in 
tumour sections from day 28 tumours following completion of infusion, analysed by 
H&E staining, increased significantly in treated mice (p=0.049, t-test). (c) Tumour 
growth was monitored by bioluminescence and (d) the ratio of signal per tumour 
volume shows a significant decrease in treated mice after 17 days (p=0.0415, Mann 
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Supplementary Figure S14 
PI3 kinase inhibitors exhibit synergistic interactions with the IGF2-TRAP (Fc-
domain 11AB5-RHH) in SKNMC-FLAG-IGF21-104, SKNMC-IGF21-67 and STA-ET1. 
(a) Cell viability (growth) assays displaying effects of SKNMC-FLAG-IGF21-104 
autocrine IGF2 expression compared to luciferase only SKNMC controls. (b) Effect 
of the IGF2-TRAP on the cell viability of SKNMC-FLAG-IGF21-104. A concentration 
of 250 nM of the IGF2-TRAP shows a 10-20% reduction in cell viability and was 
chosen as the fixed concentration.  Insert: Western blot analysis of the effect on the 
IGF2-TRAP on the IGF2 signaling pathway of the SKNMC-FLAG-IGF2104 cell line 
shows that treatment with the IGF2-TRAP inhibits phosphorylation of pAKT 
(Ser473). (c) Dose response curves for the selected PI3kinase inhibitors (PF-
04691502 and Pictilisib) in the presence (green) and absence (blue) of the IGF2-
TRAP. Cell viability (Abs 490nm for MTS assay) is normalised to the untreated cells 
viability.  IC50 values are shown.  A leftward shift of the dose response curve for the 
combination of the drugs with IGF2-TRAP when compared with single-agent curves 
indicates synergism (P<0.0001 when comparing the IC50 of drug alone vs drug + 
IGF2-TRAP using the F-test).  Pictilisib exhibits synergistic activity with STA-ET1.  
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